SARS-CoV-2 RT-PCR assessment in asymptomatic versus symptomatic patients from a tertiary care center with recovery monitoring: A study from Kathmandu, Nepal
DOI:
https://doi.org/10.3126/jbs.v12i1.82128Keywords:
COVID-19, cycle Threshold-CT, Nepal, SARS-CoV-2, pandemicAbstract
Background: The SARS-CoV-2 infection led to a global health crisis with both symptomatic and asymptomatic cases emerging. This study aimed to study the prevalence of SARS-CoV-2 among both symptomatic and asymptomatic patients visiting a tertiary care hospital in Nepal and to assess the viral load variations in COVID-19 positive cases throughout the recovery period.
Material and methods: A cross-sectional study was conducted on symptomatic and asymptomatic patients visiting Shahid Gangalal National Heart Centre, Kathmandu, Nepal, over a five-month study period from December 2021 to March 2022. The real-time (RT) PCR was performed to confirm the presence of SARS-CoV-2, and the reporting was done in terms of the cycle threshold (Ct) value.
Results: A total of 3738 samples were tested for SARS-CoV-2 during the study. Among 526(14.1%) cases that tested positive, 423(80.4%) were symptomatic and 103(19.6%) were asymptomatic. The common symptoms observed in the COVID-19 patients in our study were cough and fever. Additionally, by tracking the PCR reports of available patients concerning Ct value, we found that 81.5% of patients recovered by the third week of infection, with individuals aged 60 years or older taking the longest to recover.
Conclusion: The findings highlight the prevalence of asymptomatic cases that were widespread during the pandemic. It also implies that the use of reliable diagnostic techniques like RT-PCR with its specific Ct value is important in managing and controlling pandemics like COVID-19.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.